Source: Annual Congress 2006 - Lung cancer, haemoptoe, smoking and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Ucar, F. Yardim, O. Orsel, S. Alpar, S. F. Guven, B. Kurt (Ankara, Bolu, Turkey). Shall we disclose the diagnosis of lung cancer to the patient?. Eur Respir J 2006; 28: Suppl. 50, 344

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary function in elderly patients with diagnosis of lung cancer – an excuse for giving up surgery? Source: Annual Congress 2008 - Congenital lung lesions and emphysema; lung cancer surgery Year: 2008 Patient and doctor delay in the diagnosis and treatment of lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 749s Year: 2006 An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer Source: Annual Congress 2006 - MP11 - An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer Year: 2006 How do lung cancer patients die? Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours Year: 2008 Truth telling to lung cancer diagnosed patients and expectations for taking responsibility at treatment Source: Eur Respir J 2004; 24: Suppl. 48, 229s Year: 2004 Poor performance status patient in advanced lung cancer: to treat or not to treat? Source: Annual Congress 2008 - MP13 - Poor performance status patient in advanced lung cancer: to treat or not to treat? Year: 2008 Detection of operable lung cancer – a question of sheer luck? Source: Eur Respir J 2007; 30: Suppl. 51, 563s Year: 2007 Quality of life in lung cancer: does disclosing of the diagnosis have an impact? Source: Annual Congress 2003 - Lung cancer management and prognosis Year: 2003 Management of incidental nodules in lung cancer screening: ready for prime-time? Source: Breathe, 15 (4) 346; 10.1183/20734735.0247-2019 Year: 2019 Granulomatous reaction in a patient with lung cancer: should we treat it? Source: Breathe, 14 (3) e94; 10.1183/20734735.014617 Year: 2018 Breath biomarkers for lung cancer detection: ready for use by the pulmonologist? Source: Annual Congress 2012 - PG18 Recent evolutions in screening and early diagnosis of lung cancer Year: 2012 Non-small cell lung cancer: how do experts want to be treated? Source: Virtual Congress 2021 – COVID-19 and management of lung cancer Year: 2021 Treatment of early lung disease – is it possible? Does it work? Source: Annual Congress 2004 - PG19 - Screening for cystic fibrosis: diagnose early - treat early Year: 2004 Who should treat lung cancer patients and where should they be treated? Source: Annual Congress 2009 - Fitness for radical therapy in lung cancer patients Year: 2009 Diagnosing lung cancer: is the 28 day rule appropriate? Source: Eur Respir J 2004; 24: Suppl. 48, 298s Year: 2004 Patients referred to a lung cancer clinic – does a clinical assessment at the outset have an impact on the investigations requested? Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology Year: 2008 What’s new in interstitial lung diseases in children? Source: Virtual Congress 2021 – Paediatric year in review Year: 2021 Lung cancer: clinical presentation and specialist referral time Source: Eur Respir J 2004; 24: 898-904 Year: 2004